Revance Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 346k | 8.77 |
| 2023-09-30 | $3.0M | 262k | 11.33 |
| 2023-03-31 | $9.5M | 295k | 32.21 |
| 2022-12-31 | $18M | 959k | 18.46 |
| 2022-09-30 | $64M | 2.5M | 25.97 |
| 2021-12-31 | $2.4M | 148k | 16.32 |
| 2021-03-31 | $269k | 9.7k | 27.65 |
| 2020-12-31 | $582k | 20k | 29.41 |
| 2020-09-30 | $280k | 11k | 24.96 |
| 2020-06-30 | $630k | 26k | 24.48 |
| 2020-03-31 | $318k | 21k | 15.07 |
| 2019-12-31 | $218k | 15k | 14.29 |
| 2019-09-30 | $385k | 27k | 14.29 |
| 2019-06-30 | $336k | 26k | 13.02 |
| 2019-03-31 | $416k | 27k | 15.50 |
| 2018-12-31 | $405k | 20k | 20.16 |
| 2018-09-30 | $213k | 8.6k | 24.83 |
| 2018-06-30 | $6.0k | 207 | 28.99 |
| 2018-03-31 | $11k | 344 | 31.98 |
| 2017-12-31 | $14k | 404 | 34.65 |
| 2017-09-30 | $8.0k | 277 | 28.88 |
| 2017-06-30 | $6.0k | 240 | 25.00 |
| 2017-03-31 | $7.0k | 313 | 22.36 |
| 2016-12-31 | $6.0k | 269 | 22.30 |
| 2016-09-30 | $4.0k | 269 | 14.87 |
| 2016-06-30 | $87k | 6.4k | 13.60 |
| 2015-12-31 | $364k | 11k | 34.17 |
| 2015-09-30 | $0 | 9 | 0.00 |
| 2015-06-30 | $105k | 3.3k | 31.90 |
| 2014-09-30 | $6.0k | 300 | 20.00 |
| 2014-03-31 | $35k | 1.1k | 31.56 |